A prime-boost immunization regimen based on a simian adenovirus 36 vectored multi-stage malaria vaccine induces protective immunity in mice

Keyphrases

• Protective Immunity 100%
• Simian Adenovirus 100%
• Prime-boost Vaccination 100%
• Malaria Vaccine 100%
• Adenovirus 36 100%
• Immunization Regimen 100%
• Recombinant 66%
• CD8+ T Cells 66%
• Yoelii 66%
• Pre-erythrocytic Stages 66%
• Immune Response 33%
• Virus 33%
• Public Health 33%
• Vaccine Research 33%
• Highly Effective 33%
• Cell Response 33%
• High Prevalence 33%
• CD4+ T 33%
• Viral Vectors 33%
• CD8+ T Cell Response 33%
• Antibody Titer 33%
• Malaria 33%
• MSP-1 33%
• Vaccine Candidate 33%
• Protective Antibodies 33%
• Human Adenovirus Type 5 33%
• Infection Challenge 33%
• Parasite Load 33%
• Rodent Malaria Parasites 33%
• Pre-existing Immunity 33%
• Protein-based Vaccine 33%
• Heterologous Prime-boost 33%
• Load Following 33%
• Vaccine Construct 33%
• Malaria Cases 33%
• Experimental Vaccines 33%

Immunology and Microbiology

• Cytotoxic T-Cell 100%
• Simian Virus 100%
• Immunology 100%
• Prevalence 33%
• T-Helper Cell 33%
• Immune Response 33%
• Plasmodium 33%
• Adoptive Immunity 33%
• Antibody Titer 33%
• Viral Vector 33%
• Parasite Load 33%
• Human Adenovirus 5 33%